S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer

NCT00445848 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

89

Enrollment

NETWORK

Sponsor class

Conditions

Lung Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: erlotinib hydrochloride

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]